TAK-438 - Safety, Blood Levels & Effects of Repeated Doses
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of
TAK-438 in healthy, non-Japanese men male subjects following a randomized, double blind,
placebo controlled, sequential panel, multiple-dose schedule.